Bhavesh Ashar, Chief Commercial Officer at SpringWorks Therapeutics, Inc. (SWTX), sold 2,032 shares at $61.19 ($124K) on 2025-02-20, disclosed to the SEC on 2025-02-24.
Scheduled sale ($124k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.19 | 1,016 | $62K | 50.0% |
| 2 | $61.19 | 1,016 | $62K | 50.0% |
| Total | $61.19 avg | 2,032 | $124K | 100% |